Zoetis
$150.92
24H
Market Cap
Volume
Supply
Price Chart
About Zoetis - ZTS
Zoetis Inc. is a global company that focuses on the discovery, development, manufacture, and commercialisation of veterinary vaccines and medicines for pets and livestock. It was formerly a subsidiary of Pfizer, the largest global pharmaceutical company, before becoming an independent company through an initial public offering.
What are Zoetis's core values and mission statement?
Zoetis Inc.'s core values revolve around customer focus, innovation, accountability, teamwork, and integrity. The company's mission is to build on a six-decade history and singular focus on animal health to bring customers quality products, services, and a commitment to their businesses.
Who founded Zoetis and when?
Zoetis Inc. was not founded by an individual but rather was created as a result of a spin-off from Pfizer, the global pharmaceutical company, with its formation as a separate company occurring in 2013.
Who leads Zoetis?
As of the time of information available, Zoetis Inc. is led by Kristin Peck, who serves as the Chief Executive Officer.
Where is Zoetis located, and what is its base country?
Zoetis Inc. is headquartered in Parsippany, New Jersey, USA. The company is based in the United States.
On which exchanges is Zoetis traded?
Zoetis Inc. is traded on the New York Stock Exchange (NYSE) under the ticker symbol "ZTS".
Historical data
Zoetis (ZTS) Price Live Data
The live price of Zoetis (ZTS) is $150.92, with a trading volume of 3,184,032 in the last 24 hours. Wrapstocks updates the ZTS price in real-time. Zoetis is up 0.91% in the last 24 hours. The company has a live market cap of $68,960,157,696.00 and a supply of 456,947,008 ZTS stocks.
Zoetis (ZTS) is traded on New York Stock Exchange, and currently, the market is closed; trading will be resumed in 13 hours and 50 minutes.
![REG HEALTH FPO [REG] 24 hours chart.](https://cdn.wrapstocks.com/trendassets/graph_REG.AX_24H.png)
